Rezolute Inc reports results for the quarter ended March 31 - Earnings Summary

• Rezolute Inc RZLT.OQ reported a quarterly adjusted loss of 27 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -34 cents. The mean expectation of nine analysts for the quarter was for a loss of 22 cents per share. Wall Street expected results to range from -26 cents to -17 cents per share.

• Reported revenue was zero​; analysts expected zero.

• Rezolute Inc's reported EPS for the quarter was a loss of 27 cents​.

• The company reported a quarterly loss of $18.91 million.

• Rezolute Inc shares had risen by 28.6% this quarter and lost 23.9% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 9.3% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for Rezolute Inc is $14.00

This summary was machine generated from LSEG data May 13 at 09:08 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)